📣 VC round data is live. Check it out!

Andon Health Valuation Multiples

Discover Andon Health's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Bausch + Lomb, Getinge, Snibe, Renishaw and more.

Andon Health Overview

About Andon Health

Andon Health Co Ltd is a China-based company. It is principally engaged in the research and development, manufacture and distribution of medical instruments. Its main products include a blood pressure monitor, blood glucose monitor, TENS, electrical muscle stimulator, electronic pulse massager, and a digital thermometer.


Founded

1995

HQ

China

Employees

N/A

Website

jiuan.com

Financials (FY)

Revenue: $202M
EBITDA: $401M

EV

$5B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Andon Health Financials

Andon Health reported last fiscal year revenue of $202M and EBITDA of $401M.

In the same fiscal year, Andon Health generated $129M in gross profit, $401M in EBITDA, and $335M in net income.

Revenue (LTM)


Andon Health P&L

In the most recent fiscal year, Andon Health reported revenue of $202M and EBITDA of $401M.

Andon Health is profitable as of last fiscal year, with gross margin of 64%, EBITDA margin of 199%, and net margin of 166%.

See analyst estimates for Andon Health
Last FY202320242025202620272028
Revenue$202M$478M$383M$202M
Gross Profit$129M$304M$271M$129M
Gross Margin64%64%71%64%
EBITDA$401M$251M$331M$401M
EBITDA Margin199%53%86%199%
EBIT Margin(22%)26%27%(22%)
Net Profit$335M$185M$247M$335M
Net Margin166%39%64%166%
Net Debt$113M---

Financial data powered by Morningstar, Inc.

Andon Health Stock Performance

Andon Health has current market cap of $5B, and enterprise value of $5B.

Market Cap Evolution


Andon Health's stock price is $11.50.

Andon Health share price increased by 2.2% in the last 30 days, and by 117.4% in the last year.

Andon Health has an EPS (earnings per share) of $0.72.

See more trading valuation data for Andon Health
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$5B$5B0.0%2.2%6.5%117.4%$0.72

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Andon Health Valuation Multiples

Andon Health trades at 25.2x EV/Revenue multiple, and 12.7x EV/EBITDA.

See NTM and 2027E valuation multiples for Andon Health

EV / Revenue (LTM)


Andon Health Financial Valuation Multiples

As of June 4, 2026, Andon Health has market cap of $5B and EV of $5B.

Andon Health has a P/E ratio of 16.0x.

Last FY202320242025202620272028
EV/Revenue25.2x10.6x13.3x25.2x
EV/EBITDA12.7x20.2x15.3x12.7x
EV/EBIT(115.9x)40.4x48.6x(115.9x)
EV/Gross Profit39.4x16.7x18.8x39.4x
P/E16.0x29.0x21.7x16.0x
EV/FCF(79.7x)22.1x37.6x(79.7x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Andon Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Andon Health Margins & Growth Rates

In the most recent fiscal year, Andon Health reported gross margin of 64%, EBITDA margin of 199%, and net margin of 166%.

See estimated margins and future growth rates for Andon Health

Andon Health Margins

Last FY20242025202720282029
Gross Margin64%71%64%
EBITDA Margin199%86%199%
EBIT Margin(22%)27%(22%)
Net Margin166%64%166%
FCF Margin(32%)35%(32%)

Andon Health Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(20%)(47%)
Gross Profit Growth(11%)(52%)
EBITDA Growth32%21%
EBIT Growth(17%)(142%)
Net Profit Growth33%36%
FCF Growth(41%)(147%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Andon Health Operational KPIs

Access forward-looking KPIs for Andon Health
Last FY202320242025202620272028
S&M Expenses to Revenue24%12%16%24%
G&A Expenses to Revenue15%6%5%15%
R&D Expenses to Revenue24%9%10%24%
Opex to Revenue86%37%43%86%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Andon Health Competitors

Andon Health competitors include Bausch + Lomb, Getinge, Snibe, Renishaw, Teleflex, Sysmex, Convatec Group, Ypsomed, Hamamatsu Photonics and Abbott India.

Most Andon Health public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Bausch + Lomb2.0x1.9x11.4x10.7x
Getinge1.6x1.6x8.6x8.6x
Snibe7.2x6.9x16.1x15.7x
Renishaw5.1x4.7x22.8x20.8x
Teleflex4.0x3.7x13.0x13.1x
Sysmex1.7x1.7x7.2x8.6x
Convatec Group2.7x2.6x10.1x9.8x
Ypsomed6.4x6.4x14.3x14.6x

This data is available for Pro users. Sign up to see all Andon Health competitors and their valuation data.

Start Free Trial

Investments by Andon Health

Andon Health has invested in 3 companies to date.

Latest investment by Andon Health was on March 31st 2026. Andon Health invested in OakDeer Robotics in their $44M Undisclosed stage round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Andon Health

OakDeer Robotics
Hengyu Medical
HeyPlus
Description
OakDeer Robotics is a Chinese robotics company developing smart cooking machines designed to improve food processing efficiency. The firm focuses on automated culinary equipment for commercial and consumer applications. Operates as a subsidiary of Oak Heron Technology.
Hengyu Medical is a Suzhou-based producer of intravascular ultrasound systems, optical coherence tomography catheters, and related interventional devices. The company supplies imaging equipment to hospitals in China and exports to Southeast Asia for cardiovascular diagnostics and treatments.
HeyPlus is a provider of advanced algorithms for smart wearable devices, targeting researchers and developers in the health monitoring sector. Its smartwatches incorporate features like 100-plus exercise modes, wrist-lift gesture recognition, continuous heart rate tracking, blood oxygen saturation measurement, pedometer functionality, and multi-stage sleep analysis. Based in China, the company supplies embedded software solutions that achieve over 95 percent accuracy in biometric readings for consumer and professional wearables.
HQ CountryChinaChinaChina
HQ City
Beijing
Tianjin
Shenzhen
Deal Date31 Mar 202621 Feb 202524 Apr 2019
RoundUndisclosed stageSeries ASeries A
Raised$44M$14M$2M
InvestorsAmbrum Capital; Andon Health; Beijing E-town International Investment & Development; Haitang FundAndon Health; BioVenture; Haitang Fund; Huatai Zijin Investment; Xingong Industrial InvestmentAndon Health
Valuationundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Andon Health investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Andon Health

When was Andon Health founded?Andon Health was founded in 1995.
Where is Andon Health headquartered?Andon Health is headquartered in China.
Is Andon Health publicly listed?Yes, Andon Health is a public company listed on Shenzhen Stock Exchange.
What is the stock symbol of Andon Health?Andon Health trades under 002432 ticker.
When did Andon Health go public?Andon Health went public in 2010.
Who are competitors of Andon Health?Andon Health main competitors include Bausch + Lomb, Getinge, Snibe, Renishaw, Teleflex, Sysmex, Convatec Group, Ypsomed, Hamamatsu Photonics, Abbott India.
What is the current market cap of Andon Health?Andon Health's current market cap is $5B.
What is the current revenue of Andon Health?Andon Health's last fiscal year revenue is $202M.
What is the current EV/Revenue multiple of Andon Health?Current revenue multiple of Andon Health is 25.2x.
Is Andon Health profitable?No, Andon Health is not profitable.
How many companies Andon Health has acquired to date?Andon Health hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Andon Health has invested to date?As of June 2026, Andon Health has invested in 3 companies.
In what companies Andon Health invested in?Andon Health invested in OakDeer Robotics, Hengyu Medical, and HeyPlus.

See public comps similar to Andon Health

Lists including Andon Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial